Recommended AS Intensity?

[baw1955]

Without giving it much thought since my surgery on Oct 9, 2018 -- I am officially on "active surveillance". On Jan 29, 2019 my blood was drawn for an ultra-sensitive PSA test. The result was <0.006 ng/mL, non-detectable, using Roche ECLIA methodology (are there other methodologies). My URO's surveillance program is another PSA test in three months. Is this a sufficient level of monitoring? My biopsy results were GS 4+3 on two samples (28% and 16%), GS 3+4 on two samples (50% and 33%), and GS 3+3 on two samples (1% and 12%).

[Tall_Allen]

It's a technicality, but you are not on active surveillance. AS refers to a program of lab tests, DREs, imaging and biopsies undertaken by men who intend to have primary treatment if their cancer progresses. You are simply monitoring after surgery. I don't understand why you are giving your biopsy outcomes at this point. You should have outcomes from your post-prostatectomy pathology report, which provides more and better into - including Gleason scores of all tumors, their size, surgical margins, EPE, SVI. Those risk factors are taken into account when deciding what to do about any rise in PSA. Quarterly PSAs are appropriate for the first year.

[LVRob129]

Personally I would check every 6-8 months. 3 seems a bit too close together. My recommendation is now that all the work is done, go have a good time in life without the worry.